カテゴリー： 世界, 医療/バイオ, LP Information

世界の核放射線治療薬市場予測 2023年-2029年

【英語タイトル】Global Nuclear Radiation Therapeutic Drugs
Market Growth 2023-2029

LP Informationが出版した調査資料（LP23DC02254）・商品コード：LP23DC02254
・発行会社（調査会社）：LP Information
・発行日：2023年11月（※2025年版があります。お問い合わせください。）
・ページ数：101
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
・産業分野：医療機器＆消耗品
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,660 ⇒換算￥519,720見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,490 ⇒換算￥779,580見積依頼/購入/質問フォーム
Corporate User（閲覧人数制限なし）USD7,320 ⇒換算￥1,039,440見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

LPインフォメーションの最新刊調査レポート「世界の核放射線治療薬市場」は、過去の販売実績から2022年の世界の核放射線治療薬の総販売量を検討し、2023年から2029年の予測される核放射線治療薬の販売量を地域別・市場分野別に包括的に分析しています。本調査レポートでは、地域別、市場分野別、サブセクター別の核放射線治療薬の市場規模を掲載し、XXX百万米ドル規模の世界の核放射線治療薬市場の詳細な分析を提供します。本インサイトレポートは、世界の核放射線治療薬業界を包括的に分析し、製品セグメント、企業情報、売上、市場シェア、最新動向、M&A活動に関する主要トレンドを明らかにしています。

また、本レポートでは、加速する世界の核放射線治療薬市場における各社の独自のポジションをより深く理解するために、核放射線治療薬製品ポートフォリオ、能力、市場参入戦略、市場でのポジション、海外展開に焦点を当て、主要なグローバル企業の戦略を分析しています。

世界の核放射線治療薬市場規模は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに成長すると予測され、2023年から2029年までの年平均成長率は000%と予測されます。核放射線治療薬の米国市場は、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加し、2023年から2029年までのCAGRは000％と予測されています。核放射線治療薬の中国市場は、2023年から2029年までの年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されます。核放射線治療薬のヨーロッパ市場は、2023年から2029年にかけて年平均000％成長率で、2022年のXXX百万米ドルから2029年にはXXX百万米ドルに増加すると推定されています。

核放射線治療薬の世界主要メーカーとしては、Nihon Medi-Physics Co.,Ltd.、 Curium Pharma、 Cardinal Health、 Bayer Global、 GE Healthcare、 Mallinckrodt Pharmaceuticals、 Bracco Group、 Advanced Molecular-imaging Solution、 Ciaeriar、 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.などを掲載しており、売上の面では、世界の2大企業が2022年にほぼ000％のシェアを占めています。

本レポートでは、製品タイプ、用途、主要メーカー、主要地域、国別の核放射線治療薬市場の包括的な概要、市場シェア、成長機会などの情報を提供しています。

【市場細分化】

この調査では核放射線治療薬市場をセグメンテーションし、種類別 (診断、治療)、用途別 (腫瘍科、甲状腺科、循環器科、その他)、および地域別 (アジア太平洋、南北アメリカ、ヨーロッパ、および中東・アフリカ) の市場規模を予測しています。

・種類別区分：診断、治療

・用途別区分：腫瘍科、甲状腺科、循環器科、その他

・地域別区分
南北アメリカ（アメリカ、カナダ、メキシコ、ブラジル）
アジア太平洋（中国、日本、韓国、東南アジア、インド、オーストラリア）
ヨーロッパ（ドイツ、フランス、イギリス、イタリア、ロシア）
中東・アフリカ（エジプト、南アフリカ、イスラエル、トルコ、GCC諸国）

【本レポートで扱う主な質問】

・世界の核放射線治療薬市場の10年間の市場状況・展望は？
・世界および地域別に見た核放射線治療薬市場成長の要因は何か？
・核放射線治療薬の市場機会はエンドマーケットの規模によってどのように変化するのか？
・核放射線治療薬のタイプ別、用途別の内訳は？
・新型コロナウイルス感染症とロシア・ウクライナ戦争の影響は？

********* 目次 *********

レポートの範囲
・市場の紹介
・分析対象期間
・調査の目的
・調査手法
・調査プロセスおよびデータソース
・経済指標
・通貨

エグゼクティブサマリー
・世界市場の概要：核放射線治療薬の年間販売量2018-2029、地域別現状・将来分析
・核放射線治療薬の種類別セグメント：診断、治療
・核放射線治療薬の種類別販売量：2018-2023年の販売量、売上、市場シェア、販売価格
・核放射線治療薬の用途別セグメント：腫瘍科、甲状腺科、循環器科、その他
・核放射線治療薬の用途別販売量：2018-2023年の販売量、売上、市場シェア、販売価格

企業別世界の核放射線治療薬市場
・企業別のグローバル核放射線治療薬市場データ：2018-2023年の年間販売量、市場シェア
・企業別の核放射線治療薬の年間売上：2018-2023年の売上、市場シェア
・企業別の核放射線治療薬販売価格
・主要企業の核放射線治療薬生産地域、販売地域、製品タイプ
・市場集中度分析
・新製品および潜在的な参加者
・合併と買収、拡大

核放射線治療薬の地域別レビュー
・地域別の核放射線治療薬市場規模2018-2023：年間販売量、売上
・主要国別の核放射線治療薬市場規模2018-2023：年間販売量、売上
・南北アメリカの核放射線治療薬販売の成長
・アジア太平洋の核放射線治療薬販売の成長
・ヨーロッパの核放射線治療薬販売の成長
・中東・アフリカの核放射線治療薬販売の成長

南北アメリカ市場
・南北アメリカの国別の核放射線治療薬販売量、売上（2018-2023）
・南北アメリカの核放射線治療薬の種類別販売量
・南北アメリカの核放射線治療薬の用途別販売量
・アメリカ市場
・カナダ市場
・メキシコ市場
・ブラジル市場

アジア太平洋市場
・アジア太平洋の国別の核放射線治療薬販売量、売上（2018-2023）
・アジア太平洋の核放射線治療薬の種類別販売量
・アジア太平洋の核放射線治療薬の用途別販売量
・中国市場
・日本市場
・韓国市場
・東南アジア市場
・インド市場
・オーストラリア市場
・台湾市場

ヨーロッパ市場
・ヨーロッパの国別の核放射線治療薬販売量、売上（2018-2023）
・ヨーロッパの核放射線治療薬の種類別販売量
・ヨーロッパの核放射線治療薬の用途別販売量
・ドイツ市場
・フランス市場
・イギリス市場
・イタリア市場
・ロシア市場

中東・アフリカ市場
・中東・アフリカの国別の核放射線治療薬販売量、売上（2018-2023）
・中東・アフリカの核放射線治療薬の種類別販売量
・中東・アフリカの核放射線治療薬の用途別販売量
・エジプト市場
・南アフリカ市場
・イスラエル市場
・トルコ市場
・GCC諸国市場

市場の成長要因、課題、動向
・市場の成長要因および成長機会分析
・市場の課題およびリスク
・市場動向

製造コスト構造分析
・原材料とサプライヤー
・核放射線治療薬の製造コスト構造分析
・核放射線治療薬の製造プロセス分析
・核放射線治療薬の産業チェーン構造

マーケティング、販売業者および顧客
・販売チャンネル：直接販売チャンネル、間接販売チャンネル
・核放射線治療薬の主要なグローバル販売業者
・核放射線治療薬の主要なグローバル顧客

地域別の核放射線治療薬市場予測レビュー
・地域別の核放射線治療薬市場規模予測（2024-2029）
・南北アメリカの国別予測
・アジア太平洋の国別予測
・ヨーロッパの国別予測
・核放射線治療薬の種類別市場規模予測
・核放射線治療薬の用途別市場規模予測

主要企業分析
Nihon Medi-Physics Co.,Ltd.、 Curium Pharma、 Cardinal Health、 Bayer Global、 GE Healthcare、 Mallinckrodt Pharmaceuticals、 Bracco Group、 Advanced Molecular-imaging Solution、 Ciaeriar、 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
・企業情報
・核放射線治療薬製品
・核放射線治療薬販売量、売上、価格、粗利益（2018-2023）
・主要ビジネス概要
・最新動向

調査結果および結論

The global Nuclear Radiation Therapeutic Drugs

market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Nuclear Radiation Therapeutic Drugs

is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Nuclear Radiation Therapeutic Drugs

is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Nuclear Radiation Therapeutic Drugs

is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Nuclear Radiation Therapeutic Drugs

players cover Nihon Medi-Physics Co.,Ltd., Curium Pharma, Cardinal Health, Bayer Global, GE Healthcare, Mallinckrodt Pharmaceuticals, Bracco Group, Advanced Molecular-imaging Solution and Ciaeriar, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Nuclear Radiation Therapeutic Drugs consist primarily of a radioactive isotope that is incorporated into a drug to assess the disease state in the body. The drug is used to deliver the radioactive isotope to an organ, tissue or specific cell in the body.
LPI (LP Information)’ newest research report, the “Nuclear Radiation Therapeutic Drugs

Industry Forecast” looks at past sales and reviews total world Nuclear Radiation Therapeutic Drugs

sales in 2022, providing a comprehensive analysis by region and market sector of projected Nuclear Radiation Therapeutic Drugs

sales for 2023 through 2029. With Nuclear Radiation Therapeutic Drugs

sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Nuclear Radiation Therapeutic Drugs

industry.
This Insight Report provides a comprehensive analysis of the global Nuclear Radiation Therapeutic Drugs

landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Nuclear Radiation Therapeutic Drugs

portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Nuclear Radiation Therapeutic Drugs

market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Nuclear Radiation Therapeutic Drugs

and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Nuclear Radiation Therapeutic Drugs

.
This report presents a comprehensive overview, market shares, and growth opportunities of Nuclear Radiation Therapeutic Drugs

market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
Diagnostic
Therapeutic
Segmentation by application
Oncology
Thyroid
Cardiology
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company’s coverage, product portfolio, its market penetration.
Nihon Medi-Physics Co.,Ltd.
Curium Pharma
Cardinal Health
Bayer Global
GE Healthcare
Mallinckrodt Pharmaceuticals
Bracco Group
Advanced Molecular-imaging Solution
Ciaeriar
Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Nuclear Radiation Therapeutic Drugs

market?
What factors are driving Nuclear Radiation Therapeutic Drugs

market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Nuclear Radiation Therapeutic Drugs

market opportunities vary by end market size?
How does Nuclear Radiation Therapeutic Drugs

break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?

❖ レポートの目次 ❖

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Nuclear Radiation Therapeutic Drugs

Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Nuclear Radiation Therapeutic Drugs

by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Nuclear Radiation Therapeutic Drugs

by Country/Region, 2018, 2022 & 2029
2.2 Nuclear Radiation Therapeutic Drugs

Segment by Type
2.2.1 Diagnostic
2.2.2 Therapeutic
2.3 Nuclear Radiation Therapeutic Drugs

Sales by Type
2.3.1 Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Type (2018-2023)
2.3.2 Global Nuclear Radiation Therapeutic Drugs

Revenue and Market Share by Type (2018-2023)
2.3.3 Global Nuclear Radiation Therapeutic Drugs

Sale Price by Type (2018-2023)
2.4 Nuclear Radiation Therapeutic Drugs

Segment by Application
2.4.1 Oncology
2.4.2 Thyroid
2.4.3 Cardiology
2.4.4 Others
2.5 Nuclear Radiation Therapeutic Drugs

Sales by Application
2.5.1 Global Nuclear Radiation Therapeutic Drugs

Sale Market Share by Application (2018-2023)
2.5.2 Global Nuclear Radiation Therapeutic Drugs

Revenue and Market Share by Application (2018-2023)
2.5.3 Global Nuclear Radiation Therapeutic Drugs

Sale Price by Application (2018-2023)
3 Global Nuclear Radiation Therapeutic Drugs

by Company
3.1 Global Nuclear Radiation Therapeutic Drugs

Breakdown Data by Company
3.1.1 Global Nuclear Radiation Therapeutic Drugs

Annual Sales by Company (2018-2023)
3.1.2 Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Company (2018-2023)
3.2 Global Nuclear Radiation Therapeutic Drugs

Annual Revenue by Company (2018-2023)
3.2.1 Global Nuclear Radiation Therapeutic Drugs

Revenue by Company (2018-2023)
3.2.2 Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Company (2018-2023)
3.3 Global Nuclear Radiation Therapeutic Drugs

Sale Price by Company
3.4 Key Manufacturers Nuclear Radiation Therapeutic Drugs

Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Nuclear Radiation Therapeutic Drugs

Product Location Distribution
3.4.2 Players Nuclear Radiation Therapeutic Drugs

Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Nuclear Radiation Therapeutic Drugs

by Geographic Region
4.1 World Historic Nuclear Radiation Therapeutic Drugs

Market Size by Geographic Region (2018-2023)
4.1.1 Global Nuclear Radiation Therapeutic Drugs

Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Nuclear Radiation Therapeutic Drugs

Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Nuclear Radiation Therapeutic Drugs

Market Size by Country/Region (2018-2023)
4.2.1 Global Nuclear Radiation Therapeutic Drugs

Annual Sales by Country/Region (2018-2023)
4.2.2 Global Nuclear Radiation Therapeutic Drugs

Annual Revenue by Country/Region (2018-2023)
4.3 Americas Nuclear Radiation Therapeutic Drugs

Sales Growth
4.4 APAC Nuclear Radiation Therapeutic Drugs

Sales Growth
4.5 Europe Nuclear Radiation Therapeutic Drugs

Sales Growth
4.6 Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales Growth
5 Americas
5.1 Americas Nuclear Radiation Therapeutic Drugs

Sales by Country
5.1.1 Americas Nuclear Radiation Therapeutic Drugs

Sales by Country (2018-2023)
5.1.2 Americas Nuclear Radiation Therapeutic Drugs

Revenue by Country (2018-2023)
5.2 Americas Nuclear Radiation Therapeutic Drugs

Sales by Type
5.3 Americas Nuclear Radiation Therapeutic Drugs

Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Nuclear Radiation Therapeutic Drugs

Sales by Region
6.1.1 APAC Nuclear Radiation Therapeutic Drugs

Sales by Region (2018-2023)
6.1.2 APAC Nuclear Radiation Therapeutic Drugs

Revenue by Region (2018-2023)
6.2 APAC Nuclear Radiation Therapeutic Drugs

Sales by Type
6.3 APAC Nuclear Radiation Therapeutic Drugs

Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Nuclear Radiation Therapeutic Drugs

by Country
7.1.1 Europe Nuclear Radiation Therapeutic Drugs

Sales by Country (2018-2023)
7.1.2 Europe Nuclear Radiation Therapeutic Drugs

Revenue by Country (2018-2023)
7.2 Europe Nuclear Radiation Therapeutic Drugs

Sales by Type
7.3 Europe Nuclear Radiation Therapeutic Drugs

Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Nuclear Radiation Therapeutic Drugs

by Country
8.1.1 Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales by Country (2018-2023)
8.1.2 Middle East & Africa Nuclear Radiation Therapeutic Drugs

Revenue by Country (2018-2023)
8.2 Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales by Type
8.3 Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Nuclear Radiation Therapeutic Drugs

10.3 Manufacturing Process Analysis of Nuclear Radiation Therapeutic Drugs

10.4 Industry Chain Structure of Nuclear Radiation Therapeutic Drugs

11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Nuclear Radiation Therapeutic Drugs

Distributors
11.3 Nuclear Radiation Therapeutic Drugs

Customer
12 World Forecast Review for Nuclear Radiation Therapeutic Drugs

by Geographic Region
12.1 Global Nuclear Radiation Therapeutic Drugs

Market Size Forecast by Region
12.1.1 Global Nuclear Radiation Therapeutic Drugs

Forecast by Region (2024-2029)
12.1.2 Global Nuclear Radiation Therapeutic Drugs

Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Nuclear Radiation Therapeutic Drugs

Forecast by Type
12.7 Global Nuclear Radiation Therapeutic Drugs

Forecast by Application
13 Key Players Analysis
13.1 Nihon Medi-Physics Co.,Ltd.
13.1.1 Nihon Medi-Physics Co.,Ltd. Company Information
13.1.2 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.1.3 Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Nihon Medi-Physics Co.,Ltd. Main Business Overview
13.1.5 Nihon Medi-Physics Co.,Ltd. Latest Developments
13.2 Curium Pharma
13.2.1 Curium Pharma Company Information
13.2.2 Curium Pharma Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.2.3 Curium Pharma Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Curium Pharma Main Business Overview
13.2.5 Curium Pharma Latest Developments
13.3 Cardinal Health
13.3.1 Cardinal Health Company Information
13.3.2 Cardinal Health Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.3.3 Cardinal Health Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Cardinal Health Main Business Overview
13.3.5 Cardinal Health Latest Developments
13.4 Bayer Global
13.4.1 Bayer Global Company Information
13.4.2 Bayer Global Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.4.3 Bayer Global Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Bayer Global Main Business Overview
13.4.5 Bayer Global Latest Developments
13.5 GE Healthcare
13.5.1 GE Healthcare Company Information
13.5.2 GE Healthcare Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.5.3 GE Healthcare Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 GE Healthcare Main Business Overview
13.5.5 GE Healthcare Latest Developments
13.6 Mallinckrodt Pharmaceuticals
13.6.1 Mallinckrodt Pharmaceuticals Company Information
13.6.2 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.6.3 Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 Mallinckrodt Pharmaceuticals Main Business Overview
13.6.5 Mallinckrodt Pharmaceuticals Latest Developments
13.7 Bracco Group
13.7.1 Bracco Group Company Information
13.7.2 Bracco Group Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.7.3 Bracco Group Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Bracco Group Main Business Overview
13.7.5 Bracco Group Latest Developments
13.8 Advanced Molecular-imaging Solution
13.8.1 Advanced Molecular-imaging Solution Company Information
13.8.2 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.8.3 Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Advanced Molecular-imaging Solution Main Business Overview
13.8.5 Advanced Molecular-imaging Solution Latest Developments
13.9 Ciaeriar
13.9.1 Ciaeriar Company Information
13.9.2 Ciaeriar Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.9.3 Ciaeriar Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Ciaeriar Main Business Overview
13.9.5 Ciaeriar Latest Developments
13.10 Shanghai Atom Kexing Pharmaceutical Co.,Ltd.
13.10.1 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Company Information
13.10.2 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
13.10.3 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs

Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Main Business Overview
13.10.5 Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Nuclear Radiation Therapeutic Drugs

Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Nuclear Radiation Therapeutic Drugs

Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Diagnostic
Table 4. Major Players of Therapeutic
Table 5. Global Nuclear Radiation Therapeutic Drugs

Sales by Type (2018-2023) & (Units)
Table 6. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Type (2018-2023)
Table 7. Global Nuclear Radiation Therapeutic Drugs

Revenue by Type (2018-2023) & ($ million)
Table 8. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Type (2018-2023)
Table 9. Global Nuclear Radiation Therapeutic Drugs

Sale Price by Type (2018-2023) & (US$/Unit)
Table 10. Global Nuclear Radiation Therapeutic Drugs

Sales by Application (2018-2023) & (Units)
Table 11. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Application (2018-2023)
Table 12. Global Nuclear Radiation Therapeutic Drugs

Revenue by Application (2018-2023)
Table 13. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Application (2018-2023)
Table 14. Global Nuclear Radiation Therapeutic Drugs

Sale Price by Application (2018-2023) & (US$/Unit)
Table 15. Global Nuclear Radiation Therapeutic Drugs

Sales by Company (2018-2023) & (Units)
Table 16. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Company (2018-2023)
Table 17. Global Nuclear Radiation Therapeutic Drugs

Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Company (2018-2023)
Table 19. Global Nuclear Radiation Therapeutic Drugs

Sale Price by Company (2018-2023) & (US$/Unit)
Table 20. Key Manufacturers Nuclear Radiation Therapeutic Drugs

Producing Area Distribution and Sales Area
Table 21. Players Nuclear Radiation Therapeutic Drugs

Products Offered
Table 22. Nuclear Radiation Therapeutic Drugs

Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Nuclear Radiation Therapeutic Drugs

Sales by Geographic Region (2018-2023) & (Units)
Table 26. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share Geographic Region (2018-2023)
Table 27. Global Nuclear Radiation Therapeutic Drugs

Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Nuclear Radiation Therapeutic Drugs

Sales by Country/Region (2018-2023) & (Units)
Table 30. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Country/Region (2018-2023)
Table 31. Global Nuclear Radiation Therapeutic Drugs

Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Nuclear Radiation Therapeutic Drugs

Sales by Country (2018-2023) & (Units)
Table 34. Americas Nuclear Radiation Therapeutic Drugs

Sales Market Share by Country (2018-2023)
Table 35. Americas Nuclear Radiation Therapeutic Drugs

Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Country (2018-2023)
Table 37. Americas Nuclear Radiation Therapeutic Drugs

Sales by Type (2018-2023) & (Units)
Table 38. Americas Nuclear Radiation Therapeutic Drugs

Sales by Application (2018-2023) & (Units)
Table 39. APAC Nuclear Radiation Therapeutic Drugs

Sales by Region (2018-2023) & (Units)
Table 40. APAC Nuclear Radiation Therapeutic Drugs

Sales Market Share by Region (2018-2023)
Table 41. APAC Nuclear Radiation Therapeutic Drugs

Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Region (2018-2023)
Table 43. APAC Nuclear Radiation Therapeutic Drugs

Sales by Type (2018-2023) & (Units)
Table 44. APAC Nuclear Radiation Therapeutic Drugs

Sales by Application (2018-2023) & (Units)
Table 45. Europe Nuclear Radiation Therapeutic Drugs

Sales by Country (2018-2023) & (Units)
Table 46. Europe Nuclear Radiation Therapeutic Drugs

Sales Market Share by Country (2018-2023)
Table 47. Europe Nuclear Radiation Therapeutic Drugs

Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Country (2018-2023)
Table 49. Europe Nuclear Radiation Therapeutic Drugs

Sales by Type (2018-2023) & (Units)
Table 50. Europe Nuclear Radiation Therapeutic Drugs

Sales by Application (2018-2023) & (Units)
Table 51. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales by Country (2018-2023) & (Units)
Table 52. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales by Type (2018-2023) & (Units)
Table 56. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales by Application (2018-2023) & (Units)
Table 57. Key Market Drivers & Growth Opportunities of Nuclear Radiation Therapeutic Drugs


Table 58. Key Market Challenges & Risks of Nuclear Radiation Therapeutic Drugs


Table 59. Key Industry Trends of Nuclear Radiation Therapeutic Drugs


Table 60. Nuclear Radiation Therapeutic Drugs

Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Nuclear Radiation Therapeutic Drugs

Distributors List
Table 63. Nuclear Radiation Therapeutic Drugs

Customer List
Table 64. Global Nuclear Radiation Therapeutic Drugs

Sales Forecast by Region (2024-2029) & (Units)
Table 65. Global Nuclear Radiation Therapeutic Drugs

Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Nuclear Radiation Therapeutic Drugs

Sales Forecast by Country (2024-2029) & (Units)
Table 67. Americas Nuclear Radiation Therapeutic Drugs

Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Nuclear Radiation Therapeutic Drugs

Sales Forecast by Region (2024-2029) & (Units)
Table 69. APAC Nuclear Radiation Therapeutic Drugs

Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Nuclear Radiation Therapeutic Drugs

Sales Forecast by Country (2024-2029) & (Units)
Table 71. Europe Nuclear Radiation Therapeutic Drugs

Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales Forecast by Country (2024-2029) & (Units)
Table 73. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Nuclear Radiation Therapeutic Drugs

Sales Forecast by Type (2024-2029) & (Units)
Table 75. Global Nuclear Radiation Therapeutic Drugs

Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Nuclear Radiation Therapeutic Drugs

Sales Forecast by Application (2024-2029) & (Units)
Table 77. Global Nuclear Radiation Therapeutic Drugs

Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Nihon Medi-Physics Co.,Ltd. Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 79. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 80. Nihon Medi-Physics Co.,Ltd. Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 81. Nihon Medi-Physics Co.,Ltd. Main Business
Table 82. Nihon Medi-Physics Co.,Ltd. Latest Developments
Table 83. Curium Pharma Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 84. Curium Pharma Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 85. Curium Pharma Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 86. Curium Pharma Main Business
Table 87. Curium Pharma Latest Developments
Table 88. Cardinal Health Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 89. Cardinal Health Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 90. Cardinal Health Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 91. Cardinal Health Main Business
Table 92. Cardinal Health Latest Developments
Table 93. Bayer Global Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 94. Bayer Global Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 95. Bayer Global Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 96. Bayer Global Main Business
Table 97. Bayer Global Latest Developments
Table 98. GE Healthcare Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 99. GE Healthcare Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 100. GE Healthcare Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 101. GE Healthcare Main Business
Table 102. GE Healthcare Latest Developments
Table 103. Mallinckrodt Pharmaceuticals Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 104. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 105. Mallinckrodt Pharmaceuticals Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 106. Mallinckrodt Pharmaceuticals Main Business
Table 107. Mallinckrodt Pharmaceuticals Latest Developments
Table 108. Bracco Group Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 109. Bracco Group Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 110. Bracco Group Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 111. Bracco Group Main Business
Table 112. Bracco Group Latest Developments
Table 113. Advanced Molecular-imaging Solution Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 114. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 115. Advanced Molecular-imaging Solution Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 116. Advanced Molecular-imaging Solution Main Business
Table 117. Advanced Molecular-imaging Solution Latest Developments
Table 118. Ciaeriar Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 119. Ciaeriar Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 120. Ciaeriar Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 121. Ciaeriar Main Business
Table 122. Ciaeriar Latest Developments
Table 123. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Basic Information, Nuclear Radiation Therapeutic Drugs

Manufacturing Base, Sales Area and Its Competitors
Table 124. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs

Product Portfolios and Specifications
Table 125. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Nuclear Radiation Therapeutic Drugs

Sales (Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 126. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Main Business
Table 127. Shanghai Atom Kexing Pharmaceutical Co.,Ltd. Latest Developments
List of Figures
Figure 1. Picture of Nuclear Radiation Therapeutic Drugs


Figure 2. Nuclear Radiation Therapeutic Drugs

Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Nuclear Radiation Therapeutic Drugs

Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Nuclear Radiation Therapeutic Drugs

Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Nuclear Radiation Therapeutic Drugs

Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Diagnostic
Figure 10. Product Picture of Therapeutic
Figure 11. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Type in 2022
Figure 12. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Type (2018-2023)
Figure 13. Nuclear Radiation Therapeutic Drugs

Consumed in Oncology
Figure 14. Global Nuclear Radiation Therapeutic Drugs

Market: Oncology (2018-2023) & (Units)
Figure 15. Nuclear Radiation Therapeutic Drugs

Consumed in Thyroid
Figure 16. Global Nuclear Radiation Therapeutic Drugs

Market: Thyroid (2018-2023) & (Units)
Figure 17. Nuclear Radiation Therapeutic Drugs

Consumed in Cardiology
Figure 18. Global Nuclear Radiation Therapeutic Drugs

Market: Cardiology (2018-2023) & (Units)
Figure 19. Nuclear Radiation Therapeutic Drugs

Consumed in Others
Figure 20. Global Nuclear Radiation Therapeutic Drugs

Market: Others (2018-2023) & (Units)
Figure 21. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Application (2022)
Figure 22. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Application in 2022
Figure 23. Nuclear Radiation Therapeutic Drugs

Sales Market by Company in 2022 (Units)
Figure 24. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Company in 2022
Figure 25. Nuclear Radiation Therapeutic Drugs

Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Company in 2022
Figure 27. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Nuclear Radiation Therapeutic Drugs

Sales 2018-2023 (Units)
Figure 30. Americas Nuclear Radiation Therapeutic Drugs

Revenue 2018-2023 ($ Millions)
Figure 31. APAC Nuclear Radiation Therapeutic Drugs

Sales 2018-2023 (Units)
Figure 32. APAC Nuclear Radiation Therapeutic Drugs

Revenue 2018-2023 ($ Millions)
Figure 33. Europe Nuclear Radiation Therapeutic Drugs

Sales 2018-2023 (Units)
Figure 34. Europe Nuclear Radiation Therapeutic Drugs

Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales 2018-2023 (Units)
Figure 36. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Revenue 2018-2023 ($ Millions)
Figure 37. Americas Nuclear Radiation Therapeutic Drugs

Sales Market Share by Country in 2022
Figure 38. Americas Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Country in 2022
Figure 39. Americas Nuclear Radiation Therapeutic Drugs

Sales Market Share by Type (2018-2023)
Figure 40. Americas Nuclear Radiation Therapeutic Drugs

Sales Market Share by Application (2018-2023)
Figure 41. United States Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Nuclear Radiation Therapeutic Drugs

Sales Market Share by Region in 2022
Figure 46. APAC Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Regions in 2022
Figure 47. APAC Nuclear Radiation Therapeutic Drugs

Sales Market Share by Type (2018-2023)
Figure 48. APAC Nuclear Radiation Therapeutic Drugs

Sales Market Share by Application (2018-2023)
Figure 49. China Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Nuclear Radiation Therapeutic Drugs

Sales Market Share by Country in 2022
Figure 57. Europe Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Country in 2022
Figure 58. Europe Nuclear Radiation Therapeutic Drugs

Sales Market Share by Type (2018-2023)
Figure 59. Europe Nuclear Radiation Therapeutic Drugs

Sales Market Share by Application (2018-2023)
Figure 60. Germany Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Nuclear Radiation Therapeutic Drugs

Sales Market Share by Application (2018-2023)
Figure 69. Egypt Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Nuclear Radiation Therapeutic Drugs

Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Nuclear Radiation Therapeutic Drugs

in 2022
Figure 75. Manufacturing Process Analysis of Nuclear Radiation Therapeutic Drugs


Figure 76. Industry Chain Structure of Nuclear Radiation Therapeutic Drugs


Figure 77. Channels of Distribution
Figure 78. Global Nuclear Radiation Therapeutic Drugs

Sales Market Forecast by Region (2024-2029)
Figure 79. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Nuclear Radiation Therapeutic Drugs

Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Nuclear Radiation Therapeutic Drugs

Revenue Market Share Forecast by Application (2024-2029)


★調査レポート[世界の核放射線治療薬市場予測 2023年-2029年] (コード：LP23DC02254)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の核放射線治療薬市場予測 2023年-2029年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の疼痛治療注射市場予測 2023年-2029年
  • 世界の放射線遮蔽シート市場予測 2023年-2029年
  • 世界の治療用栄養素&ミネラル市場予測 2023年-2029年
  • 世界の静脈瘤治療用ソックス市場予測 2023年-2029年
  • 世界の空圧波治療器市場予測 2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆